The significance of serum leptin level in patients with early stage nonsmall cell lung cancer

Karatas F., YALÇIN B., Sahin S., AKBULUT H., UTKAN G., DEMİRKAZIK A., ...Daha Fazla

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, cilt.13, sa.2, ss.204-207, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4103/0973-1482.196859
  • Dergi Adı: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.204-207
  • Anahtar Kelimeler: Adenocarcinoma subtype, cachexia, leptin, nonsmall cell lung cancer, operability, significance, CLINICAL-SIGNIFICANCE, RISK-FACTOR, ADIPONECTIN, RECEPTOR, PEPTIDE
  • Ankara Üniversitesi Adresli: Evet

Özet

Backgrounds: The serum leptin level (SLL) has been shown to increase in patients with nonsmall cell lung cancer (NSCLC). However, available data regarding the relation between SLL and tumor subtypes, survival, cachexia, and tumor respectability in NSCLC are still under debate. The aim of this study is to evaluate SLL in NSCLC patients with and without cachexia.